Nasdaq:SHC
Sotera Health Co
A leading US-based provider of technology-enabled healthcare services leveraging remote monitoring to improve patient outcomes and reduce hospital readmissions.
Key Metrics
Investment Thesis
Bull Case
Investors may buy Sotera Health due to its clear path to profitability, evidenced by the consistent revenue growth from $1.00B in 2022 to $1.16B in 2025 and the transition from significant net losses to positive earnings. The robust balance sheet with $346.5M in cash provides ample liquidity for strategic acquisitions or R&D investments without immediate need for external financing.
Bear Case
Concerns remain regarding the high debt load of $2.13B in long-term obligations, which requires significant interest coverage despite the improved operating profile. The substantial accumulated deficit of -$532.1M suggests historical burn rates that investors must monitor to ensure the current profitability is sustainable rather than a one-time anomaly.
About Sotera Health Co
Sotera Health provides technology-enabled healthcare services and solutions across the United States, with a focus on improving patient outcomes through remote monitoring and care coordination. The company operates primarily in the US market, serving hospitals, physicians, and payers with scalable platforms that enhance operational efficiency.
Analysis
Management Discussion
In 2025, Sotera Health demonstrated significant operational improvement with net profit reaching $77.9M, a stark turnaround from losses in previous years. The company generated strong operating cash flow of $287.2M and increased its cash position to $346.5M despite substantial capital expenditures of $138.0M for technology infrastructure and debt repayments of $86.1M.
Industry Overview
The US healthcare technology market is rapidly expanding as providers and payers prioritize digital transformation to manage rising costs and address provider shortages. Companies offering remote patient monitoring and AI-driven care coordination are seeing increased adoption, but the sector remains highly competitive with low barriers to entry for basic software solutions.
Financial Statements
Income Statement
Balance Sheet
Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | $1.00B | $1.05B | $1.10B | $1.16B |
| Cost of Revenue | $446.7M | $472.1M | $498.1M | $518.1M |
| Gross Profit | $557.0M | $577.2M | $602.3M | $645.5M |
| Operating Expenses | $308.7M | $300.5M | $304.7M | $498.0M |
| Operating Income | $248.3M | $276.7M | $297.6M | $147.5M |
| G&A | $245.7M | $236.7M | $242.6M | $252.8M |
| Stock-Based Comp | $21.2M | $32.2M | $36.8M | $30.9M |
| D&A | $64.3M | $76.6M | $84.3M | $94.9M |
| Depreciation | $64.0M | $76.6M | $84.3M | $94.9M |
| Amortization | $81.6M | $81.3M | $79.4M | $41.8M |
| Other OpEx | $62.9M | $63.8M | $62.0M | $245.3M |
| Non-Operating Income | $-491.5M | $-170.7M | $-183.8M | $0 |
| Pre-Tax Income | $-243.1M | $106.0M | $113.9M | $147.5M |
| Income Tax | $-9.5M | $54.7M | $69.5M | $69.6M |
| Continuing Ops | $-233.6M | $51.4M | $44.4M | $77.9M |
| Discontinued Ops | $0 | $0 | $0 | $0 |
| Net Income | $-233.6M | $51.4M | $44.4M | $77.9M |
| Minority Interest | $0 | $0 | $0 | $0 |
| Net to Common | $-233.6M | $51.4M | $44.4M | $77.9M |
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Current Assets | $645.0M | $557.2M | $526.0M | $613.4M |
| Cash & Equivalents | $395.2M | $296.4M | $277.2M | $344.6M |
| Accounts Receivable | $118.5M | $147.7M | $140.3M | $139.3M |
| Inventory | $37.1M | $48.3M | $49.2M | $54.4M |
| Prepaid Expenses | $81.0M | $53.8M | $51.0M | $65.2M |
| Other Current Assets | $13.2M | $11.0M | $8.3M | $9.8M |
| Long-Term Assets | $2.47B | $2.57B | $2.55B | $2.65B |
| Intangibles | $491.3M | $416.3M | $317.7M | $288.2M |
| Goodwill | $1.10B | $1.11B | $1.08B | $1.10B |
| Operating Leases | $26.5M | $24.0M | $27.6M | $33.4M |
| Other LT Assets | $853.2M | $1.02B | $1.12B | $1.22B |
| Total Assets | $3.12B | $3.13B | $3.07B | $3.26B |
| Current Liabilities | $791.6M | $230.7M | $191.0M | $249.6M |
| Accounts Payable | $74.1M | $71.0M | $55.1M | $78.0M |
| Current Debt | $197.1M | $4.8M | $14.8M | $14.0M |
| Current Leases | $7.6M | $5.9M | $5.1M | $5.8M |
| Deferred Revenue | $12.1M | $13.5M | $15.1M | $18.0M |
| Taxes Payable | $5.9M | $4.2M | $7.6M | $5.7M |
| Other Current Liab | $4.6M | $8.8M | $2.9M | $3.5M |
| Long-Term Liabilities | $1.98B | $2.46B | $2.48B | $2.41B |
| Long-Term Debt | $1.75B | $2.22B | $2.21B | $2.13B |
| LT Operating Leases | $21.6M | $20.1M | $24.5M | $29.9M |
| Other LT Liab | $207.2M | $212.3M | $243.2M | $250.9M |
| Total Liabilities | $2.77B | $2.69B | $2.67B | $2.66B |
| Shareholders' Equity | $350.2M | $443.7M | $404.9M | $606.0M |
| Paid-In Capital | $1.19B | $1.22B | $1.24B | $1.26B |
| Retained Earnings | $-705.8M | $-654.4M | $-610.0M | $-532.1M |
| AOCI | $-106.7M | $-92.7M | $-208.3M | $-109.8M |
| Treasury Stock | $29.8M | $27.2M | — | $17.0M |
| Total L&E | $3.12B | $3.13B | $3.07B | $3.26B |
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Net Income (CFO) | $-233.6M | $51.4M | $44.4M | $77.9M |
| Non-Cash Adjustments | $493.3M | $-224.4M | $175.8M | $199.4M |
| Working Capital Changes | $18.3M | $25.3M | $3.9M | $9.9M |
| Cash from Operations | $278.0M | $-147.7M | $224.2M | $287.2M |
| Capital Expenditures | $182.4M | $215.0M | $179.1M | $138.0M |
| Cash from Investing | $-181.9M | $-214.9M | $-179.0M | $-135.1M |
| Debt Issuances | $200.0M | $500.0M | $2.26B | $0 |
| Debt Repayments | $0 | $2.5M | $2.26B | $86.1M |
| Share Buybacks | $0 | — | — | — |
| Cash from Financing | $197.8M | $266.0M | $-50.6M | $-100.5M |
| FX Effect | $-4.5M | $2.0M | $-17.4M | $16.1M |
| Net Change in Cash | $289.4M | $-94.6M | $-22.8M | $67.6M |
| Beginning Cash | $106.9M | $396.3M | $301.7M | $278.9M |
| Ending Cash | $396.3M | $301.7M | $278.9M | $346.5M |
Frequently Asked Questions
How does Sotera Health Co make money?
The company's revenue is driven by technology-enabled care management services, including remote patient monitoring and chronic disease management programs. Additional streams come from data analytics solutions for payers and providers, as well as specialized service contracts for hospital networks seeking to optimize operational workflows and reduce costs.
What are the main risks for SHC?
The healthcare technology sector faces intense price competition and margin pressure as payers seek cost containment measures that may impact service fees. Regulatory changes in the US regarding data privacy, interoperability standards, and reimbursement policies could disrupt current business models or increase compliance costs. Dependence on a concentrated customer base within the US hospital system exposes the company to potential revenue volatility if key contracts are renegotiated.
What is SHC's competitive advantage?
Sotera Health possesses a proprietary data analytics platform that integrates with diverse clinical systems to personalize care plans at scale. The company benefits from deep relationships with major US healthcare systems and payers, creating high switching costs and stable recurring revenue. Its established clinical network allows for rapid deployment of remote monitoring solutions compared to newer entrants.
Related Companies
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.